World Health Organization (WHO) defines Pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. It aims to promote the safe and effective use of medicinal products, in particular through providing timely information about the safety of medicinal products to patients, healthcare professionals and public.

Adverse Drug Reaction, as per WHO 1972 is defined as a response to a drug which is noxious and unintended and which occurs at doses normally used in human for the prophylaxis, diagnosis or therapy of disease or for the modifications of physiological function.

Adverse Events, is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.

Pharmacovigilance/ Adverse Event Reporting 

The subject of pharmacovigilance is emerging in our country. We, at Yetichem highly encourage patients and users to report any unexpected events which are other than the therapeutic effects cause due to use of our products.

While reporting any adverse events to Yetichem, these four components need to be considered:

P (Patient): patients full name, age, date of birth, gender, contact detail and address of patient
R (Reporter): name of the reporter, contact detail of reporter and their relation with the patient
E (Event): description of the event as stated by the patient
P (Product): name of the product, only if the generic name of the drug is reported, it still should be reported.

[Note]: if any of these components are missing, you should still report to Yetichem at the given contact detail or you can email us at below mentioned contact details

Also, you can directly put down your queries to our mailbox.